AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Products, L.P.; AVEO Receives $15 Million; Eligible for up to $540 Million
5/31/2011 6:21:05 AM
More...
|
Centocor Ortho Biotech Products, L.P. and Amgen (AMGN) Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
2/16/2010 8:38:20 AM
More...
|
FDA Issues Complete Response Letter For Centocor Ortho Biotech Products, L.P.'s Trabectedin Combined With DOXIL; Agency Requests Additional Information
9/10/2009 11:08:44 AM
More...
|